S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John E. Godwin, MD, MS
Loyola University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
151 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alta Bates Comprehensive Cancer Center
Berkeley, California, United States
- Mills-Peninsula Health Services
Burlingame, California, United States
- Marin Cancer Institute at Marin General Hospital
Greenbrae, California, United States
- Sutter Health Western Division Cancer Research Group
Greenbrae, California, United States
- Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center
Orange, California, United States
- California Pacific Medical Center - California Campus
San Francisco, California, United States
- Phoebe Cancer Center at Phoebe Putney Memorial Hospital
Albany, Georgia, United States
- Ccop - Atlanta Regional
Atlanta, Georgia, United States
- Northside Hospital Cancer Center
Atlanta, Georgia, United States
- Piedmont Hospital
Atlanta, Georgia, United States
- Saint Joseph'S Hospital of Atlanta
Atlanta, Georgia, United States
- Wellstar Cobb Hospital
Austell, Georgia, United States
- Charles B. Eberhart Cancer Center at Dekalb Medical Center
Decatur, Georgia, United States
- Gwinnett Medical Center
Lawrenceville, Georgia, United States
- Kennestone Cancer Center at Wellstar Kennestone Hospital
Marietta, Georgia, United States
- Southern Regional Medical Center
Riverdale, Georgia, United States
- Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center
Savannah, Georgia, United States
- Hematology Oncology Associates of Eastern Idaho
Idaho Falls, Idaho, United States
- Saint Anthony'S Hospital at Saint Anthony'S Health Center
Alton, Illinois, United States
- Decatur Memorial Hospital Cancer Care Institute
Decatur, Illinois, United States
- Veterans Affairs Medical Center - Hines
Hines, Illinois, United States
- Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois, United States
- Regional Cancer Center at Memorial Medical Center
Springfield, Illinois, United States
- St. Francis Hospital and Health Centers
Beech Grove, Indiana, United States
- Cancer Center of Kansas - Chanute
Chanute, Kansas, United States
- Cancer Center of Kansas - Dodge City
Dodge City, Kansas, United States
- Cancer Center of Kansas, P.A. - El Dorado
El Dorado, Kansas, United States
- Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas, United States
- Cancer Center of Kansas - Kingman
Kingman, Kansas, United States
- Southwest Medical Center
Liberal, Kansas, United States
- Cancer Center of Kansas - Newton
Newton, Kansas, United States
- Cancer Center of Kansas, P.A. - Parsons
Parsons, Kansas, United States
- Pratt Cancer Center of Kansas
Pratt, Kansas, United States
- Cancer Center of Kansas - Salina
Salina, Kansas, United States
- Salina Regional Health Center
Salina, Kansas, United States
- Cancer Center at Stormont-Vail Regional Health Center
Topeka, Kansas, United States
- St. Francis Comprehensive Cancer Center
Topeka, Kansas, United States
- Cancer Center of Kansas - Wellington
Wellington, Kansas, United States
- Associates in Womens Health
Wichita, Kansas, United States
- Ccop - Wichita
Wichita, Kansas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2003
- Primary completion
- 31 Dec 2005
- Completion
- 31 Oct 2010
- Last update posted
- 6 Mar 2015
- Registered enrollment
- 33
- Registry id
- NCT00049179
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.